Ticker LaunchLondon · AIM · IPO · BVX
BiVictriX Therapeutics plc
BiVictriX Therapeutics plc (BVX) was admitted to AIM on Aug 11, 2021, raising £7.5M at 20p per share. Its market capitalization at admission was about £13.2M. Brokers: SP Angel Corporate Finance LLP.
BiVictriX Therapeutics develops highly selective cancer therapeutics aimed at difficult-to-treat cancers.
- Type
- IPO
- Market
- AIM
- Ticker (TIDM)
- BVX
- Admitted
- Aug 11, 2021
- Offer price
- 20p
- Raised
- £7.5M
- Market cap at admission
- £13.2M
- Brokers
- SP Angel Corporate Finance LLP
- Sector
- Biotech & pharma
- Country
- United Kingdom
More on this listing for subscribers
- Intention-to-float date
- New money versus sale shares
- Shares in issue at admission
- ISIN
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Citius Resources PlcMain Market · Aug 25, 2021
- Likewise Group plcAIM · Aug 18, 2021
- Southern Energy Corp.AIM · Aug 10, 2021
- HydrogenOne Capital Growth plcMain Market · Jul 30, 2021
- Big Technologies plcAIM · Jul 28, 2021
- Spinnaker Acquisitions PlcMain Market · Jul 28, 2021